Animal Intestinal Health Market Report 2026

The animal intestinal health market size has grown rapidly in recent years. It will grow from $4.5 billion in 2025 to $5.01 billion in 2026 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to increasing prevalence of intestinal disorders in livestock, growth of intensive farming practices, rising awareness of animal gut health, demand for natural feed additives, adoption of probiotics and phytogenics.

The animal intestinal health market size is expected to see rapid growth in the next few years. It will grow to $7.67 billion in 2030 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to advancements in microbial probiotics, growing use of plant-based feed additives, increasing focus on aquaculture and ruminant gut health, development of innovative prebiotics and immunostimulants, expansion of liquid feed supplement solutions. Major trends in the forecast period include rising adoption of probiotics and prebiotics in livestock feed, growing use of phytogenics and herbal ingredients for gut health, increasing focus on aquaculture and poultry intestinal health, development of natural and synthetic immunostimulants, expansion of liquid and dry feed supplement forms.

The increasing adoption of livestock farming is anticipated to drive the growth of the animal intestinal health market in the future. Livestock farming involves breeding, raising, and managing domesticated animals for various purposes, primarily for food, fiber, and other by-products. Prioritizing intestinal health in livestock farming leads to improved overall animal performance, better feed efficiency, enhanced productivity, and increased nutrient absorption. It also reduces the reliance on antibiotics and promotes long-term sustainability. For instance, in July 2024, the National Agricultural Statistics Service, a branch of the U.S. Department of Agriculture, reported a 4.7% increase in expenditures by livestock farms from 2022 to 2023, reaching a total of $229.4 billion in 2023. Therefore, the growing adoption of livestock farming is expected to significantly contribute to the expansion of the animal intestinal health market.

Leading companies in the market are developing advanced and innovative products to reinforce their market position. Advanced and innovative products refer to new or improved solutions that deliver enhanced performance, precision, or functionality compared to existing offerings. For example, in June 2024, the Alltech U.S. Pork Team introduced Levelset at the World Pork Expo, a product designed to support gut health in pigs. Levelset utilizes advanced nutritional science to optimize digestive function, promote better nutrient absorption, and improve overall swine health. This innovation aims to enhance the well-being of pigs while increasing the efficiency of pork production.

In July 2023, dsm-firmenich AG, a Switzerland/Netherlands-based provider of nutrition, health, and bioscience solutions, including ingredients and technologies for animal nutrition and gut health, acquired Adare Pharma Solutions’s Adare Biome for an undisclosed amount. Through this acquisition, dsm-firmenich strengthened its capabilities in the animal intestinal health and microbiome management market by integrating Adare Biome’s postbiotic research, development, and manufacturing expertise, enhancing its gut health solutions portfolio for both pets and production animals. Adare Pharma Solutions’s Adare Biome is a France/USA-based developer and manufacturer of postbiotics and digestive health ingredients for human, pet, and production animal gut health applications.

Major companies operating in the animal intestinal health market are Koninklijke DSM N.V., Archer-Daniels-Midland Company, Kemin Industries Inc., E. I. du Pont de Nemours and Company, Cargill Incorporated, Novozymes A/S, Nutreco N.V., Chr. Hansen Holding A/S, Bluestar Adisseo Company, Dr. Eckel Animal Nutrition GmbH & Co. KG, Alltech Inc., Evonik Industries AG, Lallemand Animal Nutrition, Biorigin, AB Vista, Land O'Lakes Inc., Lesaffre, Unique Biotech, Pure Cultures LLC, Agrihealth, Arm & Hammer Animal and Food Production, BENEO GmbH, Delacon Biotechnik Ges.m.b.H., Pancosma SA, Phytobiotics Futterzusatzstoffe GmbH, Vetpharma Animal Health S.L., Vetoquinol S.A., Virbac Corporation, Wacker Chemie AG, Zoetis Inc.

Asia-Pacific was the largest region in the animal intestinal health market share in 2025. The regions covered in the animal intestinal health market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the animal intestinal health market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have impacted the animal intestinal health market by increasing the cost of imported probiotics, prebiotics, phytogenics, and immunostimulants, affecting livestock feed producers and aquaculture operators. Poultry and swine intestinal health products in North America and Europe are most affected due to reliance on imported high-quality ingredients. Positively, tariffs are encouraging local production of feed supplements, fostering innovation in cost-effective gut health solutions, and strengthening regional supply chains.

The animal intestinal health market research report is one of a series of new reports that provides animal intestinal health market statistics, including animal intestinal health industry global market size, regional shares, competitors with a animal intestinal health market share, detailed animal intestinal health market segments, market trends and opportunities, and any further data you may need to thrive in the animal intestinal health industry. This animal intestinal health market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Animal intestinal health is characterized by a stable condition wherein the microbiome and the intestinal tract exist in a mutually beneficial equilibrium, ensuring that the animal's well-being and performance are not hindered by intestinal dysfunction.

The primary categories of products within the realm of animal intestinal health comprise phytogenics, probiotics, immunostimulants, and prebiotics. Phytogenics encompass plant-derived products incorporated into feed to improve feed palatability and enhance animal performance. These products can be derived from microbial or plant sources, and they are available in various forms such as dry and liquid. Their application extends across diverse livestock categories, including poultry, swine, ruminants, and aquaculture.

The animal intestinal health market consists of sales of eubiotics and synbiotic products for animal gut health. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.